March 3 2004  

THE NETHERLANDS – 3rd March 2004.  -- Nucletron B.V., a leading vendor in providing innovative software and treatment solutions to the global Oncology community, announces clinical release of Oncentra® Treatment Planning version 1.3. The current release clearly positions Oncentra Treatment Planning as the most progressive treatment planning solution available on the market today. Based on the excellent physics foundation of Helax TMS®, the system combines ease of use and powerful functionality to generate optimal treatment plans. The Windows® based operating system and flexible-licensing options provide clinics with increased configuration choices. This latest version has been released for sales after successful clinical testing in various radiation therapy clinics in Europe and the USA.


“The latest release of Oncentra Treatment Planning strengthens the system’s position as a clinically superior planning system that provides the oncology community with features that previously have not been available.” states Rudolf Scholte, CEO and President of Nucletron B.V. “This shows Nucletron’s commitment to continuously provide advanced solutions that help provide the best quality of cancer care. The Oncentra 1.3 release also provides a clear migration path to Oncentra for new and existing users in our global installed base”.


Oncentra Treatment Planning is a PC-based planning system that supports the unique concept of distributed treatment planning. It features state of the art image contouring, registration, fusion tools, proven physics, powerful dose calculation functionality, and DICOM connectivity and is the first treatment planning system to include the Monte Carlo Electron algorithm for clinical use. The latest release offers another industry’s first with archiving capabilities to any DICOM Archive supporting DICOM RT objects. The Oncentra 1.3 release also provides a clear migration path to Oncentra for new and existing users.


“Oncology departments need to offer more complex treatments, more rapidly, with less associated costs, and therefore require advanced functionality in an easy to operate planning system. With Oncentra Treatment Planning we offer a modular treatment planning system that meets these exact requirements” states Jan Willem Hazenoot, Oncentra Business Manager, Nucletron B.V. “The planning system can be tailored to the specific requirements of radiation therapy departments, supports any clinical workflow and handles complex and simple treatment scenarios efficiently and quickly. This makes it a powerful, cost-effective choice for large and small clinics worldwide. ”


Oncentra Treatment Planning is an integral part of the Oncentra family of software products from Nucletron, a unique integrated Oncology Workflow Management system. The Oncentra system provides Oncology clinics throughout the world with an integrated treatment planning, record and verify, and information management solution. Based on DICOM, the system provides support for connectivity to existing clinical systems including diagnostic imaging PACS systems and third-party treatment planning systems.


About Nucletron B.V.


Nucletron specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in Treatment Planning, Brachytherapy, Information Management, Simulation and Service. The company has 22 offices worldwide, including its corporate headquarters in The Netherlands. For more information on Nucletron, please visit: http://www.nucletron.com/.


Nucletron B.V. is a subsidiary of Delft Instruments N.V. http://www.delftinstruments.com/Delft Instruments employs some 1,200 people, is listed on Euronext Amsterdam and is included in the NextEconomy segment. The company reported a preliminary net profit of EUR 10.4 million on turnover of around EUR 237 million in 2003.



For further information: